Joint (NASDAQ:JYNT) Upgraded at StockNews.com
by Renee Jackson · The Cerbat GemStockNews.com upgraded shares of Joint (NASDAQ:JYNT – Free Report) from a hold rating to a buy rating in a research note published on Friday morning.
Separately, Roth Mkm dropped their target price on shares of Joint from $16.00 to $15.00 and set a “buy” rating for the company in a report on Friday, November 8th.
Check Out Our Latest Stock Report on Joint
Joint Price Performance
Shares of JYNT stock opened at $11.06 on Friday. Joint has a 1-year low of $8.29 and a 1-year high of $17.82. The firm has a market cap of $165.72 million, a PE ratio of -9.70 and a beta of 1.57. The company has a 50-day moving average of $11.31 and a two-hundred day moving average of $12.95.
Institutional Trading of Joint
Institutional investors and hedge funds have recently bought and sold shares of the business. Geode Capital Management LLC grew its holdings in shares of Joint by 1.1% in the third quarter. Geode Capital Management LLC now owns 291,581 shares of the company’s stock valued at $3,336,000 after purchasing an additional 3,043 shares in the last quarter. Barclays PLC grew its stake in shares of Joint by 71.4% in the third quarter. Barclays PLC now owns 25,609 shares of the company’s stock worth $294,000 after acquiring an additional 10,671 shares in the last quarter. O Brien Greene & Co. Inc increased its position in shares of Joint by 3.5% during the third quarter. O Brien Greene & Co. Inc now owns 119,620 shares of the company’s stock worth $1,368,000 after acquiring an additional 4,000 shares during the period. BNP Paribas Financial Markets raised its stake in shares of Joint by 5.4% in the third quarter. BNP Paribas Financial Markets now owns 22,510 shares of the company’s stock valued at $258,000 after acquiring an additional 1,156 shares in the last quarter. Finally, FMR LLC boosted its holdings in Joint by 38.0% in the third quarter. FMR LLC now owns 10,787 shares of the company’s stock valued at $123,000 after purchasing an additional 2,971 shares during the period. 76.88% of the stock is currently owned by hedge funds and other institutional investors.
About Joint
The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
Featured Stories
- Five stocks we like better than Joint
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside